Search
Findings provide further proof of concept that pharmacological targeting of airway smooth muscle thickness will be beneficial and may be facilitated by azithromycin
This review focuses on smokers and nonsmokers and evaluates the most recent data regarding the potential health effects of e-cigarettes
The need to understand responses to extreme environments has prompted this edition of Current Opinion in Endocrine and Metabolic Research
Sex and intrauterine growth restriction independently affect diaphragm contraction in adult mice without changes in structure
There are a multitude of ways that, with respect to early-life exposures and health, electronic nicotine delivery systems are a cause for concern
Exposure to biodiesel exhaust resulted in significantly greater cell death and a greater release of immune mediators compared to both air controls and ULSD exhaust
While maternal high fat diet compromised litter survival, it also promoted somatic and lung growth (increased lung volume) in the offspring
These data provide proof of concept supporting the rationale for developing transplacental immune reprogramming approaches for primary disease prevention
Electronic cigarettes (e-cigarettes) are often perceived to be a less harmful alternative to tobacco cigarettes. Potentially due to this perception, they are used by people with pre-existing respiratory conditions, such as asthma, who otherwise would not smoke. Despite this, there are few studies exploring the health effects of e-cigarette use on pre-existing asthma.
Mucopolysaccharidosis type IIIA (MPS IIIA) is characterized by neurological and skeletal pathologies caused by reduced activity of the lysosomal hydrolase, sulfamidase, and the subsequent primary accumulation of undegraded heparan sulfate (HS). Respiratory pathology is considered secondary in MPS IIIA and the mechanisms are not well understood.